Celularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in Allogeneic Cellular Therapy
Company Blog Articles
Thank you for joining the conference call to introduce the proposed merger agreement between GX Acquisition Corp. and Celularity Inc....
Your browser does not support the audio element. TranscriptThank you for joining the conference call to introduce the proposed merger...
As a company leading the innovation in off-the-shelf cellular medicines for Cancer, Infectious Diseases, and Degenerative Diseases, Celularity has the...
LifebankUSA, powered by Celularity Inc, and the world’s most comprehensive company for cord, placenta and tissue banking, today unveils a...
April 2, 2020
FDA Green-Lights Clinical Trial For COVID-19 Coronavirus Treatment That ‘Flattens The Curve’ In Patients
Therapeutics startup Celularity announced Thursday morning that it has received FDA clearance to begin a clinical trial of a proposed...
April 2, 2020
Venture-backed Celularity receives FDA approval for early trials of a new cell therapy for COVID-19
Celularity, the venture-backed developer of novel cell therapies for cancer treatments, has received an initial clearance from the Food and...
